(Q34992260)

English

Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas (English)

1 reference

Europe PubMed Central

5 August 2017

1 reference

based on heuristic

inferred from title

object named as

Tom Walsh

5

0 references

Toshiyasu Taniguchi

object named as

Toshiyasu Taniguchi

3

0 references

author name string

Elizabeth M Swisher

1

1 reference

Europe PubMed Central

5 August 2017

Rachel M Gonzalez

2

1 reference

Europe PubMed Central

5 August 2017

Rochelle L Garcia

4

1 reference

Europe PubMed Central

5 August 2017

Barbara A Goff

6

1 reference

Europe PubMed Central

5 August 2017

Piri Welcsh

7

1 reference

Europe PubMed Central

5 August 2017

publication date

14 July 2009

1 reference

Europe PubMed Central

5 August 2017

Molecular Cancer

1 reference

Europe PubMed Central

5 August 2017

8

1 reference

Europe PubMed Central

5 August 2017

48

1 reference

Europe PubMed Central

5 August 2017

https://scigraph.springernature.com/pub.10.1186/1476-4598-8-48

0 references

Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Resistance to therapy caused by intragenic deletion in BRCA2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Role of BRCA1 in cellular resistance to paclitaxel and ionizing radiation in an ovarian cancer cell line carrying a defective BRCA1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Biallelic inactivation of BRCA2 in Fanconi anemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Localization of BRCA1 and a splice variant identifies the nuclear localization signal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Mutation analysis of the BRCA1 gene in ovarian cancers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

8 July 2018

Alternate molecular genetic pathways in ovarian carcinomas of common histological types.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

26 October 2018

The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

26 October 2018

Improved survival in women with BRCA-associated ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

26 October 2018

TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

26 October 2018

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

26 October 2018

Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

26 October 2018

Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

26 October 2018

Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719582

26 October 2018

Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/19602291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations of the BRCA2 gene in ovarian carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/19602291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19602291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 mutations in BRCA1-associated familial breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19602291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency of germline and somatic BRCA1 mutations in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19602291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics

1 reference

https://pubmed.ncbi.nlm.nih.gov/19602291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased frequency ofTP53 mutations inBRCA1 andBRCA2 ovarian tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/19602291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19602291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRCA1 expression in a large series of sporadic ovarian carcinomas: a Gynecologic Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19602291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRCA1 promoter methylation predicts adverse ovarian cancer prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19602291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19602291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19602291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19602291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization of human BRCA1 and BRCA2 in non-inherited colorectal carcinomas and matched normal mucosas

1 reference

https://pubmed.ncbi.nlm.nih.gov/19602291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19602291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactivation of BRCA1 and BRCA2 in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19602291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1476-4598-8-48

1 reference

Europe PubMed Central

5 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34992260&oldid=1639023249"